Kolexia
Reda Manon Oncologie médicale
Reda Manon
Oncologie médicale
Centre Georges-François Leclerc
Dijon, France
48 Activités
307 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du sein Tumeur de Wilms Neutropénie Manifestations cutanées Métastase tumorale Tumeurs du rein Troubles de la croissance Tumeurs du sein triple-négatives Tumeurs embryonnaires et germinales

Collaborateurs

Voir plus
Desmoulins Isabelle
Desmoulins Isabelle
Centre Georges-François Leclerc, Dijon, France
Hennequin Audrey
Hennequin Audrey
Centre Georges-François Leclerc, Dijon, France
Ladoire Sylvain
Ladoire Sylvain
Centre Georges-François Leclerc, Dijon, France
Nambot Sophie
Nambot Sophie
Hôpital les Chanaux, Mâcon, France

Industries

Voir plus
Lilly
2 collaboration(s)
Dernière en 2023
MSD
1 collaboration(s)
Dernière en 2022
Amgen
1 collaboration(s)
Dernière en 2022
AstraZeneca
1 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
MOSAÏQUE: Screening for Chromosomal Microarrangements by CGH-array in Developmental Anomalies of the Skin Suggestive of Mosaicism. National Multicentre Descriptive Study.
Essai Clinique (CHU Dijon-Bourgogne)   20 février 2024
Neurodevelopmental and other phenotypes recurrently associated with heterozygous BAZ2B loss-of-function variants.
American journal of medical genetics. Part A   23 octobre 2023
Advancing precision oncology through systematic germline and tumor genetic analysis: The oncogenetic point of view on findings from a prospective multicenter clinical trial of 666 patients.
Cancer medicine   11 septembre 2023
Low risk of embryonic and other cancers in PIK3CA-related overgrowth spectrum: Impact on screening recommendations.
Clinical genetics   14 août 2023
Input of PRS313 for breast cancer risk stratification in patients with atypical breast lesion
Abstracts from the 55th European Society of Human Genetics (ESHG) Conference   01 mai 2023
Clinical Utility of Genomic Tests Evaluating Homologous Recombination Repair Deficiency (HRD) for Treatment Decisions in Early and Metastatic Breast Cancer.
Cancers   18 février 2023
Taxane rechallenge during metastatic disease in HER-2 negative breast cancer patients: Clinical activity, tolerance and survival results.
Breast (Edinburgh, Scotland)   04 février 2023
Detection of relevant pharmacogenetic information through exome sequencing in oncology.
Pharmacogenomics   31 août 2022
Low risk of embryonal cancer in PIK3CA -Related Overgrowth Spectrum: impact on screening recommendations
Abstracts from the 54th European Society of Human Genetics (ESHG) Conference   01 avril 2022
Detection of relevant pharmacogenetic information through exome sequencing in oncology
Abstracts from the 54th European Society of Human Genetics (ESHG) Conference   01 avril 2022